Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2008-10-01 (17 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: PARIS (75016), Paris
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELUARL PHARMACIE LAHYANI : revenue, balance sheet and financial ratios
SELUARL PHARMACIE LAHYANI is a French company
founded 17 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in PARIS (75016),
this company of category PME
shows in 2018 a net income positive of 148 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELUARL PHARMACIE LAHYANI (SIREN 508520095)
Indicator
2018
2016
Revenue
N/C
N/C
Net income
148 412 €
160 692 €
EBITDA
N/C
N/C
Net margin
N/C
N/C
Revenue and income statement
In 2018, SELUARL PHARMACIE LAHYANI generates positive net income of 148 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2018: 161 k€ -> 148 k€.
Net income (2018)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
148 412 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 446%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 16%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2018)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
446.004%
Financial autonomy (2018)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
15.771%
Asset age ratio (2018)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
Debt ratio
445.407
446.004
Financial autonomy
15.87
15.771
Repayment capacity
None
None
Cash flow / Revenue
None%
None%
Sector positioning
Debt ratio
446.02018
2016
2018
Q1: 40.91
Med: 114.65
Q3: 265.65
Average
In 2018, the debt ratio of SELUARL PHARMACIE LAHYANI (446.00) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
15.77%2018
2016
2018
Q1: 21.63%
Med: 38.4%
Q3: 58.06%
Average
In 2018, the financial autonomy of SELUARL PHARMACIE LAHYANI (15.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 77.07. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2018)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2018
Liquidity ratio
114.369
77.066
Interest coverage
None
None
Sector positioning
Liquidity ratio
77.072018
2016
2018
Q1: 118.22
Med: 162.8
Q3: 228.3
Watch-9 pts over 2 years
In 2018, the liquidity ratio of SELUARL PHARMACIE LAHYANI (77.07) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of SELUARL PHARMACIE LAHYANI in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 177 transactions of similar company sales
in 2018,
the value of SELUARL PHARMACIE LAHYANI is estimated at
1 868 639 €
(range 1 392 717€ - 3 073 475€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2018
177 transactions
1392k€1868k€3073k€
1 868 639 €Range: 1 392 717€ - 3 073 475€
NAF 5 année 2018
Valuation method used
Net Income Multiple
148 412 €
×
12.6x
=1 868 640 €
Range: 1 392 718€ - 3 073 476€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 177 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELUARL PHARMACIE LAHYANI with other companies in the same sector:
Frequently asked questions about SELUARL PHARMACIE LAHYANI
What is the revenue of SELUARL PHARMACIE LAHYANI ?
The revenue of SELUARL PHARMACIE LAHYANI is not publicly disclosed (confidential accounts filed with INPI).
Is SELUARL PHARMACIE LAHYANI profitable?
Yes, SELUARL PHARMACIE LAHYANI generated a net profit of 148 k€ in 2018.
Where is the headquarters of SELUARL PHARMACIE LAHYANI ?
The headquarters of SELUARL PHARMACIE LAHYANI is located in PARIS (75016), in the department Paris.
Where to find the tax return of SELUARL PHARMACIE LAHYANI ?
The tax return of SELUARL PHARMACIE LAHYANI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELUARL PHARMACIE LAHYANI operate?
SELUARL PHARMACIE LAHYANI operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart